Functional lysine modification by an intrinsically reactive primary glycolytic metabolite

Science

Volumn 341, Issue 6145, 2013, Pages 549-553

  Moellering, Raymond E ^a   Cravatt, Benjamin F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIPHOSPHOGLYCERIC ACID; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCERIC ACID; GLYCOLYTIC ENZYME; LYSINE; UNCLASSIFIED DRUG;

CATALYSIS; ENZYME ACTIVITY; GLUCOSE; METABOLITE; PROTEIN; PROTEOMICS;

ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BIOSYNTHESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTROPHILICITY; ENZYME ACTIVE SITE; ENZYME INHIBITION; FEEDBACK SYSTEM; GLYCOLYSIS; HUMAN; HUMAN CELL; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REGULATORY MECHANISM;

EID: 84881077601     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1238327     Document Type: Article

References (27)

1. L. Swint-Kruse, K. S. Matthews, Curr. Opin. Microbiol. 12, 129-137 (2009).
2. M. Sola-Penna, D. Da Silva, W. S. Coelho, M. M. Marinho-Carvalho, P. Zancan, IUBMB Life 62, 791-796 (2010).
3. C. Walsh, Posttranslational Modification of Proteins: Expanding Nature's Inventory (Roberts and Co., Englewood, CO, 2006).
4. T. Wang, R. Kartika, D. A. Spiegel, J. Am. Chem. Soc. 134, 8958-8967 (2012).
5. S. G. Codreanu, B. Zhang, S. M. Sobecki, D. D. Billheimer, D. C. Liebler, Mol. Cell. Proteomics 8, 670-680 (2009).
6. C. E. Paulsen et al., Nat. Chem. Biol. 8, 57-64 (2011).
7. A. Saiardi, R. Bhandari, A. C. Resnick, A. M. Snowman, S. H. Snyder, Science 306, 2101-2105 (2004).
8. J. A. Demoss, S. M. Genuth, G. D. Novelli, Proc. Natl. Acad. Sci. U.S.A. 42, 325-332 (1956).
9. S. H. Liaw, I. Kuo, D. Eisenberg, Protein Sci. 4, 2358-2365 (1995).
10. M. P. Patricelli et al., Biochemistry 46, 350-358 (2007).
11. M. R. Larsen, T. E. Thingholm, O. N. Jensen, P. Roepstorff, T. J. Jørgensen, Mol. Cell. Proteomics 4, 873-886 (2005).
12. E. L. Huttlin et al., Cell 143, 1174-1189 (2010).
13. Primary data (.RAW files) from mouse tissue phosphoproteomes (enriched by strong cation exchange chromatography and IMAC) as reported in (12), were downloaded from the Proteome Commons public database. MS2 files were generated with RAW Xtractor and searched for pgK modified peptides by using a mouse EBI-IPI forward-reverse proteomic database as discussed in Materials and Methods. False-positive rates were between 0.0 and 0.5%.
14. W. Huang, B. T. Sherman, R. A. Lempicki, Nat. Protoc. 4, 44-57 (2009).
15. M. Mann, Nat. Rev. Mol. Cell Biol. 7, 952-958 (2006).
16. B. J. Fueger et al., J. Nucl. Med. 47, 999-1006 (2006).
17. L. Zheng, R. G. Roeder, Y. Luo, Cell 114, 255-266 (2003).
18. M. Kanwar, R. A. Kowluru, Diabetes 58, 227-234 (2009).
19. E. C. Yego, S. Mohr, J. Biol. Chem. 285, 3181-3190 (2010).
20. P. A. Sims, T. M. Larsen, R. R. Poyner, W. W. Cleland, G. H. Reed, Biochemistry 42, 8298-8306 (2003).
21. A review of literature on glycolytic enzyme modification revealed evidence for phosphate-modified forms of GAPDH and ENO1 in bacteria, which were interpreted to potentially correspond to enzymes modified by adenosine diphosphate ribosylation and substrate (2-phosphoglycerate), respectively (22). Our data offer an additional interpretation of these findings as evidence that 1,3-BPG may also modify glycolytic enzymes in bacteria.
22. G. Boël et al., J. Mol. Biol. 337, 485-496 (2004).
23. P. A. Srere, Annu. Rev. Biochem. 56, 89-124 (1987).
24. S. An, R. Kumar, E. D. Sheets, S. J. Benkovic, Science 320, 103-106 (2008).
25. M. G. Vander Heiden, L. C. Cantley, C. B. Thompson, Science 324, 1029-1033 (2009).
26. W. Yi et al., Science 337, 975-980 (2012).
27. R. Rosa, M. O. Prehu, Y. Beuzard, J. Rosa, J. Clin. Invest. 62, 907-915 (1978).